Overview

Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease

Status:
RECRUITING

Trial end date:
2027-05-30

Target enrollment:

Participant gender:

Summary

This study is a randomized clinical trial that compares the effectiveness of Plasma Rich in Growth Factors (PRGF) with conventional treatment for healing foot ulcers in diabetic patients who also have peripheral arterial disease. The goal is to assess how well PRGF promotes healing over a six-month period.

Phase:

PHASE4

Details

Lead Sponsor:

Biotechnology Institute IMASD

Collaborator:

Hospital de Basurto

Treatments:

Anti-Bacterial Agents
Intercellular Signaling Peptides and Proteins